Page breadcrumb nav

VAERS Report 2157397

Case Report Section

Détails du rapport Vaer

Âge: 1 ans

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)

Type : Measles, mumps, rubella and varicella vaccine live

Fabricant: MERCK & CO

Lot: u025964


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-01-19
Date d’apparition
7
Nombre de jours (date d’apparition – date de vaccination)
7
Description de l’événement indésirable

fever greater than equals to 39.5; information has been downloaded from the regulatory authority (it-minisal02-844729). this spontaneous report was received from a other healthcare professional referring to a 1-year-old male patient. the patient's current conditions, medical history, concomitant medications and drug reactions/allergies were not reported. on 19-jan-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (rha) (proquad), via subcutaneous route in the left deltoid (lot # u025964 has been verified to be a valid lot number and expiration date was not reported but upon internal validation was established as 31-jan-2023) (dose, strength, indication and formulation were not reported). on 26-jan-2022, the patient experienced hyperpyrexia (reported as "fever greater than equals to 39.5 (units not provided)"). on 29-jan-2022, the patient recovered from hyperpyrexia. the causality assessment was not provided. the agency considered the event "hyperpyrexia" to be medically significant

Données de laboratoire
na
Liste des symptômes
hyperpyrexia
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na